Evidence map›Paper›PMID 27046454›Full record

ArticleAddiction biology2017

Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions.

Jacques D Nguyen, Yanabel Grant, Kevin M Creehan, Sophia A Vandewater, Michael A Taffe

Open access · greenAbstract read
In one paragraph

Article in Addiction biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Animal Models of the Behavioral Symptoms of Substance Use Disorders.Cold Spring Harbor perspectives in medicine · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Lasting effects of repeated ∆British journal of pharmacology · 2020
    Article
  11. Article
  12. Article
  13. ΔNeuropharmacology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jacques D NguyenCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
Yanabel GrantCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
Kevin M CreehanCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
Sophia A VandewaterCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
Michael A TaffeCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
Scripps Research Institute · US

Funding

Determinants of transition states in MDMA self-administrationR01DA024105 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI TAFFE, MICHAEL A. · 2011 to 2015
$1.9M
NIDA NIH HHS R01 DA024105
6 · The paper itself

Abstract

The recreational use of substituted cathinones continues to grow as a public health concern in the United States. Studies have shown that extended access to intravenous (i.v.) self-administration of stimulants, such as cocaine and methamphetamine, results in escalation of drug intake relative to shorter access; however, little is known about the impact of extended access on self-administration of entactogen class stimulants such as methylone and 4-methylmethcathinone (mephedrone). Male Wistar rats were randomly assigned to short-access (ShA, 2- h) and long-access (LgA, 6- h) groups and trained to self-administer methylone or mephedrone (0.5 mg/kg/infusion) using a fixed-ratio 1 response contingency. The methylone-trained groups were evaluated on a progressive-ratio (PR) procedure incorporating dose-substitution of methylone (0.125-2.5 mg/kg/infusion), mephedrone (0.125-2.5 mg/kg/infusion) or methamphetamine (MA; 0.01-0.5 mg/kg/infusion). Mephedrone-trained rats were similarly evaluated on a PR with mephedrone and MA. Rats trained with LgA to methylone and mephedrone earned more infusions during acquisition compared with ShA groups. Mephedrone-trained LgA rats reached significantly higher breakpoints than all other groups in mephedrone and MA PR tests. Methylone-trained LgA rats exhibited a rightward shift of the peak effective dose but no overall efficacy change compared with methylone-trained ShA rats. These findings show that the self-administration of mephedrone escalates under LgA conditions in a manner similar to traditional stimulants whereas escalation of 6 h intakes of methylone is not accompanied by differences in PR performance. Thus mephedrone represents the greater risk for dysregulated drug consumption.

Indexed as

Behavior, AnimalConditioning, OperantSelf AdministrationAdministration, IntravenousAnimalsCentral Nervous System StimulantsMaleMethamphetamineRatsRats, WistarTime FactorsCentral Nervous System StimulantsmephedroneMethamphetaminemethylonebath saltsdrug addictionecstasyrewardsubstance abuse

Identifiers

PMID27046454
PMCPMC5052089
OpenAlexW2338460517

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.